Skip Navigation



NDT Advance Access published online on October 12, 2004
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfh447
© 2004 by European Renal Association - European Dialysis and Transplant Association
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
20/1/16    most recent
gfh447v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Suliman, M. E.
Right arrow Articles by Stenvinkel, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suliman, M. E.
Right arrow Articles by Stenvinkel, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial Review

Homocysteine in uraemia--a puzzling and conflicting story

Mohamed E. Suliman 1, Peter Bárány 1, Kamyar Kalantar-Zadeh 2, Bengt Lindholm 1, and Peter Stenvinkel 1*

1 Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Karolinska University Hospital at Huddinge, Stockholm, Sweden
2 Division of Nephrology and Hypertension, Harbor-UCLA Medical Center, Torrance, CA 90509, USA

* To whom correspondence should be addressed. E-mail: peter.stenvinkel{at}klinvet.ki.se.



This article has no Abstract.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Am. Soc. Nephrol.Home page
C.-C. Wu, S.-C. Wen, C.-W. Yang, S.-Y. Pu, K.-C. Tsai, and J.-W. Chen
Plasma ADMA Predicts Restenosis of Arteriovenous Fistula
J. Am. Soc. Nephrol., January 1, 2009; 20(1): 213 - 222.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
D. Stamopoulos, P. Bouziotis, D. Benaki, C. Kotsovassilis, and P. N. Zirogiannis
Utilization of nanobiotechnology in haemodialysis: mock-dialysis experiments on homocysteine
Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3234 - 3239.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
P. Stenvinkel and T. J. Ekstrom
Epigenetics--a helpful tool to better understand processes in clinical nephrology?
Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1493 - 1496.
[Full Text] [PDF]

Home page
 CJASNHome page
P. Stenvinkel, J. J. Carrero, J. Axelsson, B. Lindholm, O. Heimburger, and Z. Massy
Emerging Biomarkers for Evaluating Cardiovascular Risk in the Chronic Kidney Disease Patient: How Do New Pieces Fit into the Uremic Puzzle?
Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 505 - 521.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. Covic, P. Gusbeth-Tatomir, and D. Goldsmith
Negative outcome studies in end-stage renal disease: how dark are the storm clouds?
Nephrol. Dial. Transplant., January 1, 2008; 23(1): 56 - 61.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
I. Baragetti, S. Raselli, A. Stucchi, V. Terraneo, S. Furiani, L. Buzzi, K. Garlaschelli, E. Alberghini, A. L. Catapano, and G. Buccianti
Improvement of endothelial function in uraemic patients on peritoneal dialysis: a possible role for 5-MTHF administration
Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3292 - 3297.
[Abstract] [Full Text] [PDF]

Home page
 EuropaceHome page
C. Bruch, C. Bruch, J. Sindermann, G. Breithardt, and R. Gradaus
Prevalence and prognostic impact of comorbidities in heart failure patients with implantable cardioverter defibrillator
Europace, August 1, 2007; 9(8): 681 - 686.
[Abstract] [Full Text] [PDF]

Home page
 pdiHome page
E. Garcia-Lopez, J. J. Carrero, M. E. Suliman, B. Lindholm, and P. Stenvinkel
RISK FACTORS FOR CARDIOVASCULAR DISEASE IN PATIENTS UNDERGOING PERITONEAL DIALYSIS
Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S205 - S209.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Suliman, P. Stenvinkel, A. R. Qureshi, K. Kalantar-Zadeh, P. Barany, O. Heimburger, E. F. Vonesh, and B. Lindholm
The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation
Nephrol. Dial. Transplant., January 1, 2007; 22(1): 209 - 217.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
C. van Guldener
Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering?
Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1161 - 1166.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.